Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

Bovine mastitis research receives funding boost
Bovine mastitis is considered to be one of the most common causes of economic loss for cattle farmers worldwide.

Anifera to evaluate the ability of its leading compound to enhance antiobiotic treatment.

Animal health firm Anifera has received funding from the UK’s Centre for Innovation and Excellence in Livestock (CIEL) to conduct additional studies on bovine mastitis.

The firm will use the funding to evaluate the ability of its leading compound to enhance antibiotic treatment for Staphylococcus aureus, one of the leading causes of intramammary infections in dairy cows.

The study will be conducted in partnership with the Moredun Research Institute, and Anifera will use the results to confirm efficacy already noted in a previous small-scale study.

It also plans to explore options for the commercialisation of its compound to treat bovine mastitis.

“The project backed by CIEL, thanks to the support of Innovate UK, will greatly assist in determining the benefit that our leading compound can bring to veterinarians and dairy farmers in terms of direct reduction of mastitis and related costs,” commented Anifera board member, Dr Tony Benitz. 

“It will also help us to establish the potential of our leading compound to enable the repurposing of older antibiotics, which may no longer be considered sufficiently effective.”

Bovine mastitis is considered to be the most common cause of economic loss for cattle farmers worldwide. Rising prevalence globally and increasing pressure to curb the use of new-generation antibiotics has created the need for alternative approaches, including repurposing older and less effective antibiotics for use in livestock. 

Through its research, Anifera aims to develop compounds that can improve the efficacy of antibiotics, with the ultimate aim of reducing their use in animals. Its technology consists of a family of small molecules which, acting through a novel method of action,  are proven to increase the susceptibility of resistant strains of bacteria to antibiotics.

”The need to find innovative ways to increase the efficacy of currently-used antibiotics is becoming much more critical, with significant pressure to reduce or discontinue the use of many newer first-line therapies,” explained Anifera CEO, Dr Gwynneth Thomas. 

“We are grateful to CIEL and MRI for supporting this important study, which will allow us to move our leading compound closer to commercialisation as a more sustainable option for farmers, ultimately improving yields and quality and reducing unnecessary antibiotic use.”

Become a member or log in to add this story to your CPD history

Prestigious veterinary awards open for nominations

News Story 1
 Nominations for the prestigious PetPlan Veterinary Awards 2022 are now open, with five accolades up for grabs including: Practice of the Year; Vet of the Year, Vet Nurse of the Year, Practice Manager of the Year and Practice Support Staff.

Anyone can nominate an outstanding veterinary professional or practice for an award, from colleagues to pet owners, friends and family. Nominations remain anonymous, and Petplan will send everyone who receives a nomination a certificate to display in their practice.

Nominations can be made at and remain open until Monday 10 January. 

Click here for more...
News Shorts
New online CPD otitis podcast created

A new 15 minute podcast on treating animals with otitis has been created by Dechra Veterinary Products. Featuring general practice vet Carolyn Kyte and veterinary dermatology specialist Natalie Barnard, the two vets will discuss their experiences treating otitis, and why owners are significant in successful treatment.

Dechra Brand Manager Carol Morgan commented: "What Carolyn and Natalie bring to the table with their new podcast for the Dechra Academy is a light and insightful discussion about communication and education being the keystone for better otitis outcomes and how vets can improve on their consultation skills to handle cases better."`

The podcast, called 'Think Differently about Otitis', is available to access for free on the Dechra Academy on-demand learning platform here.